Higher circulating adiponectin levels are associated with increased insulin sensitivity and reduced hepatic fat accumulation in individuals with obesity and type 2 diabetes, whereas low adiponectin levels are indicative of metabolic dysfunction across diverse populations [14,15]. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.